Edwards gets conditional OK for U.S. trial of replacement heart valve

09/24/2010 | Forbes · Nasdaq.com

Edwards Lifesciences said it has been granted conditional approval by the FDA to conduct the first of the two clinical trials of its Sapien XT transcatheter heart valve in patients suffering from severe symptomatic aortic stenosis. The device was approved by European regulators in March.

View Full Article in:

Forbes · Nasdaq.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT